Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01169207 · ClinicalTrials.gov registry record
Johns Hopkins Crohn's Disease and Ulcerative Colitis Study
A clinical trial of Inflammatory Bowel Disease, sponsored by Johns Hopkins University.
- Active
- Registry status
- 2,500
- Enrollment target
- 1
- Study location
NCT01169207 is a study of Inflammatory Bowel Disease that is active but no longer recruiting, run by Johns Hopkins University. The registered enrollment target is 2,500 participants, above the 315-participant average among 28 other Inflammatory Bowel Disease trials with a reported enrollment target (694% higher). The trial reports 1 study location across 1 state.
The verdict
NCT01169207, a study of Inflammatory Bowel Disease, is active but no longer recruiting, sponsored by Johns Hopkins University.
- ACTIVE NOT RECRUITING
- Registry status
- 2,500 participants
- Enrollment target
- 1
- Study location
Study Summary
Inflammatory bowel disease (IBD), including Crohn's disease (CD) and ulcerative colitis (UC), is a idiopathic, chronic and frequently disabling inflammatory disorder of the intestines characterized by a dysregulated mucosal immune response that affect more than a million Americans. This current protocol was established in 1996 with the goal of identifying the genetic and environmental components that contribute to the development of IBD, especially in families.
Conditions Studied
Study Locations (1)
Maryland
- Johns Hopkins University - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,500 participants |
| Start Date | 1996-07 |
| Est. Completion | 2027-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01169207
The ClinicalTrials.gov registry entry for NCT01169207 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 2,500 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 315-participant average among 28 other Inflammatory Bowel Disease trials with a reported enrollment target (694% higher). The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Inflammatory Bowel Disease appearing as the primary indexed condition, and to 0 interventions.
NCT01169207 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT01169207 about?
NCT01169207 is a clinical study titled "Johns Hopkins Crohn's Disease and Ulcerative Colitis Study". Inflammatory bowel disease (IBD), including Crohn's disease (CD) and ulcerative colitis (UC), is a idiopathic, chronic and frequently disabling inflammatory disorder of the intestines characterized by a dysregulated mucosal immune response that affect more than a million Americans. This current prot...
What is the current status of trial NCT01169207?
This trial is currently active not recruiting. The enrollment target is 2,500 participants. The study started on 1996-07. Estimated completion is 2027-12.
What conditions does trial NCT01169207 study?
This clinical trial studies the following conditions: Inflammatory Bowel Disease.
Who is sponsoring clinical trial NCT01169207?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01169207 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Inflammatory Bowel Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Impact of Morning Light Therapy in IBD
RECRUITING · NA
-
Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer
RECRUITING · Phase 1
-
Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors
RECRUITING
-
High Dose Interval Vitamin D Supplementation in Patients With Inflammatory Bowel Disease Receiving Biologic Therapy
RECRUITING
-
A Multicenter National Prospective Study of Pregnancy and Neonatal Outcomes in Women With Inflammatory Bowel Disease
RECRUITING
-
Skeletal Health and Bone Marrow Composition in Newly Diagnosed Adolescents With Crohn Disease
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.